Satoshi Morita
Kyoto University(JP)
Publications by Year
Research Areas
Colorectal Cancer Treatments and Studies, Gastric Cancer Management and Outcomes, Lung Cancer Treatments and Mutations, Cancer Treatment and Pharmacology, HER2/EGFR in Cancer Research
Most-Cited Works
- → Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR(2010)5,537 cited
- → Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial(2009)4,101 cited
- → Safety and Antitumor Activity of Anti–PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer(2015)1,173 cited
- → Human iPS cell-derived dopaminergic neurons function in a primate Parkinson’s disease model(2017)682 cited
- → Erlotinib plus bevacizumab versus erlotinib alone in patients with EGFR-positive advanced non-squamous non-small-cell lung cancer (NEJ026): interim analysis of an open-label, randomised, multicentre, phase 3 trial(2019)630 cited
- → Randomized, Open-Label, Phase III Study Comparing Irinotecan With Paclitaxel in Patients With Advanced Gastric Cancer Without Severe Peritoneal Metastasis After Failure of Prior Combination Chemotherapy Using Fluoropyrimidine Plus Platinum: WJOG 4007 Trial